Tag: Heart Bypass
CABG May Be Best Method to Revascularize in Diabetes
Cardiac, cerebrovascular events lower in patients with multivessel coronary artery disease
CABG May Be Best for Multivessel Revascularization in T1DM
Increased risks of coronary heart disease mortality, MI, repeat revascularization with PCI
On-Pump CABG Leads to Higher Rates of Five-Year Survival
Study compared coronary-artery bypass grafting surgery, with/without cardiopulmonary bypass
Multiple Dosing Mitigates ASA Hyporesponsiveness After CABG
Multiple dosing more effective than ASA 81 or 325 mg once-daily for suppressing serum TXB2 formation
Continuing Statins Up to Surgery May Improve CABG Outcomes
Continuing medications up to and on operation day linked to better survival rates in study
Anaortic Off-Pump CABG Tied to Reduced Risk of Post-Op Stroke
AnOPCABG linked to reduced risk of mortality, renal failure, bleeding complications, atrial fibrillation
Better Teamwork Linked to Improved Outcomes for CABG
Health systems with higher teamwork levels have lower 60-day rates of ER visits, readmission, death
Five-Year Outcomes Similar for Off-, On-Pump CABG in CAD
No significant difference for composite outcome, components of the composite outcome, mean cost
CABG Plus Optimal Medical Therapy Best in T2DM and CAD
During long-term follow-up, CABG + OMT linked to reduction in composite of death, MI, stroke
Good 20-Year Patency for Radial Artery Grafts in CABG
Patency is not inferior to left internal thoracic artery; target vessel stenosis influences graft patency
